INTERNATIONAL PATENT: INSTITUT QUIMIC DE SARRIA CETS FUNDACIO PRIVADA, UNIVERSITAT RAMON LLULL FUNDACIO, XENOPAT S.L. FILES APPLICATION FOR "SUBSTITUTED 2-(PHENYLAMINO))PYRIDO[2,3-D]PYRIMIDIN-7-ONE COMPOUNDS FOR USE IN THE TREATMENT OF PANCREATIC CANCER"

GENEVA, April 27 -- INSTITUT QUIMIC DE SARRIA CETS FUNDACIO PRIVADA (Via Augusta, 39008017 BARCELONA), UNIVERSITAT RAMON LLULL FUNDACIO (C. Claravall 1-308022 BARCELONA), XENOPAT S.L. (C. Feixa Llarga sn. Edifici Bioincubadora08907 L'HOSPITALET DE LLOBREGAT) filed a patent application (PCT/EP2025/079620) for "SUBSTITUTED 2-(PHENYLAMINO))PYRIDO[2,3-D]PYRIMIDIN-7-ONE COMPOUNDS FOR USE IN THE TREATMENT OF PANCREATIC CANCER" on Oct 14, 2025. With publication no. WO/2026/082727, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ...